Exploring stakeholder perceptions of facilitators and barriers to accessing methadone  maintenance clinics in Yunnan Province, China.
Injection drug use is an ongoing public health crisis in China and one of the largest contributors to the transmission of HIV/AIDS. Though the government has rapidly scaled up methadone maintenance treatment clinics, they have not been extensively evaluated to analyze factors influencing rates of attendance. We explored the facilitators and barriers to accessing methadone maintenance clinics in Kunming City, Yunnan Province, China. Using in-depth qualitative interviews conducted from February 2008 to June 2008 with 35 informants - injection drug users (IDUs) and key stakeholders - we explored factors that determine whether drug users decide to present at methadone clinics. Interviews were digitally recorded with consent, transcribed verbatim, and translated. Content analysis was conducted to identify themes which included general attitudes toward methadone treatment, barriers and challenges to access, and suggestions for improvement. Within these, topics included responses to methadone, its side effects, and fear of discrimination, loss of privacy, and police interference. Respondents also listed numerous suggestions for improvement including raising awareness of harm reduction both among drug users and the community, providing additional support in the form of psychological counseling, job training and behavioral therapy, and increasing communication between police, government, and public health officials. High rates of HIV infection among IDUs in China have prompted public health responses including the scale up of methadone maintenance clinics. Our results may inform policy strategists in implementing social-structural changes to create enabling environments that facilitate an increase in access to methadone clinics among IDUs in Kunming.
Philbin
Morgan M
MM
Department of Health, Behavior and Society, The Johns Hopkins Bloomberg School of Public Health, 624N. Broadway, Baltimore, MD, USA. mphilbin@jhsph.edu
Zhang
Fujie
F
D000163:Acquired Immunodeficiency Syndrome / Q000517:prevention & control / Q000635:transmission; D000328:Adult; D000554:Ambulatory Care Facilities; D002681:China; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission; D040261:Harm Reduction; D006282:Health Personnel / Q000523:psychology*; D006801:Humans; D008691:Methadone / Q000627:therapeutic use*; D009294:Narcotics / Q000627:therapeutic use*; D058850:Opiate Substitution Treatment / Q000379:methods* / Q000523:psychology; D010342:Patient Acceptance of Health Care / Q000523:psychology; D036301:Qualitative Research; D015819:Substance Abuse, Intravenous / Q000523:psychology / Q000534:rehabilitation*
D009294:Narcotics; D008691:Methadone